Skip to content

Clinical trials

Phase 2 Myeloproliferative Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20091
20111
20131
20142
20151
20161
20171
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
Novartis Pharmaceuticals2
Cogent Biosciences, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Fred Hutchinson Cancer Center1
Italfarmaco1
Sierra Oncology LLC - a GSK company1
Takeda1
University of Ulm1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders12
Primary Myelofibrosis5
Hematologic Diseases4
Leukemia, Myeloid, Acute4
Polycythemia Vera4
Neoplasms3
Thrombocythemia, Essential3
Blast Crisis2
Bone Marrow Diseases2
Burkitt Lymphoma2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.